MASTL and cancer: In all these cancers, the upregulation of Gwl correlates with increased risk of relapse and poor prognosis, specifically in head and neck carcinoma [114], neuroblastoma [113] and in breast [115,116,117], gastric [119], and colorectal [120] cancers.